RecruitingNCT06614478

Frailty, Hip Fractures and Inflammatory Biomarkers

Frailty in Hip Fracture Patients Treated With Surgery; the Role of Simple Inflammatory Biomarkers. An Observational Study


Sponsor

University of Thessaly

Enrollment

200 participants

Start Date

Apr 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.


Eligibility

Min Age: 65 Years

Inclusion Criteria1

  • age \>65 years, ASA PS I-III, non- institutionalized, able to communicate patients

Exclusion Criteria1

  • Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Larissa University Hospital

Larissa, Thessaly, Greece

UHL

Larissa, Thessaly, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06614478


Related Trials